These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21346848)

  • 1. Updates in the management of hepatocellular carcinoma.
    Wong R; Frenette C
    Gastroenterol Hepatol (N Y); 2011 Jan; 7(1):16-24. PubMed ID: 21346848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
    Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.
    Shi Y; Zhai B
    Gastrointest Tumors; 2016 Oct; 3(2):90-102. PubMed ID: 27904861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidisciplinary approach to the management of hepatocellular carcinoma.
    Gish RG; Marrero JA; Benson AB
    Gastroenterol Hepatol (N Y); 2010 Mar; 6(3 Suppl 6):1-16. PubMed ID: 20567570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: early-stage management challenges.
    Erstad DJ; Tanabe KK
    J Hepatocell Carcinoma; 2017; 4():81-92. PubMed ID: 28721349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
    Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
    Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
    Gish RG; Finn RS; Marrero JA
    Gastroenterol Hepatol (N Y); 2013 Apr; 9(4 Suppl 2):1-24. PubMed ID: 24872793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in multidisciplinary management of hepatocellular carcinoma.
    Gomaa AI; Waked I
    World J Hepatol; 2015 Apr; 7(4):673-87. PubMed ID: 25866604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: locoregional and targeted therapies.
    Wong R; Frenette C; Gish R
    Gastroenterol Clin North Am; 2011 Sep; 40(3):599-610. PubMed ID: 21893276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatocellular in the United States.
    Mokdad AA; Hester CA; Singal AG; Yopp AC
    Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: natural history, current management, and emerging tools.
    Tinkle CL; Haas-Kogan D
    Biologics; 2012; 6():207-19. PubMed ID: 22904613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
    Salhab M; Canelo R
    J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
    Gish RG; Finn RS; Marrero JA
    Clin Adv Hematol Oncol; 2013 Apr; 11 Suppl 5():1-22; quiz 2 p following p22. PubMed ID: 23881427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the Diagnosis and Treatment of Hepatocellular Carcinoma.
    Ferrante ND; Pillai A; Singal AG
    Gastroenterol Hepatol (N Y); 2020 Oct; 16(10):506-516. PubMed ID: 34017223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress.
    Brown ZJ; Hewitt DB; Pawlik TM
    Expert Opin Investig Drugs; 2022 Apr; 31(4):379-391. PubMed ID: 34788184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.